Indications for Wound Care Dressings

Dressing Selection Guidelines

Dressings should be selected primarily based on exudate control, comfort, and cost, with Hydrofera Blue indicated for infected wounds requiring antimicrobial action and Mesalt for wounds requiring moisture management and exudate absorption, as recommended by the American Diabetes Association 1, 2
The International Working Group on the Diabetic Foot recommends against using topical antiseptic or antimicrobial dressings for the sole purpose of wound healing in diabetic foot ulcers, emphasizing the need for evidence-based dressing selection 3
Strong evidence does not support the routine use of antimicrobial dressings solely for the purpose of promoting wound healing, according to the American Heart Association 3, 4

Mesalt is indicated for wounds with moderate to high exudate that require absorption and moisture management, containing sodium chloride which creates an osmotic effect to draw fluid from the wound, as recommended by the American Diabetes Association 2
Mesalt is most appropriate for wounds requiring debridement of necrotic tissue through osmotic action, highly exudative wounds without clinical signs of infection, and wounds where moisture balance is the primary concern rather than infection control, according to the American Diabetes Association 2

Prolonged use of antimicrobial dressings without reassessment may lead to delayed healing and unnecessary costs, as warned by the American Heart Association 4
Antimicrobial dressings should not be relied upon as a substitute for proper wound cleansing and debridement, according to the American Heart Association 5

Regular evaluation of wounds for signs of infection, including redness, swelling, foul-smelling drainage, increased pain, or fever, is crucial for effective wound management, as recommended by the American Heart Association 5
Wounds that deteriorate or fail to improve after 2-4 weeks should be reassessed, and the dressing type changed if necessary, according to the International Working Group on the Diabetic Foot 3